Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
IVIEW Therapeutics, Inc. See All Filings	D/A	2025-06-10 13:11:30 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0001848749 Filed Document 0001848749-25-000003 Exclusions or Exemptions 506b Accepted Date 2025-06-10 13:11:30 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
IVIEW Therapeutics, Inc. See All Filings	D/A	2025-02-24 11:14:14 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0001848749 Filed Document 0001848749-25-000001 Exclusions or Exemptions 506b Accepted Date 2025-02-24 11:14:14 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
IVIEW Therapeutics, Inc. See All Filings	D	2024-05-24 11:51:35 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0001848749 Filed Document 0001848749-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-05-24 11:51:35 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
IVIEW Therapeutics, Inc. See All Filings	D/A	2022-01-12 11:29:46 UTC
Amount To Be Raised $30,027,445 Associated Brokers / Dealers N/A CIK Number 0001848749 Filed Document 0001848749-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-01-12 11:29:46 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
IVIEW Therapeutics, Inc. See All Filings	D	2021-03-12 12:13:45 UTC
Amount To Be Raised $24,027,446 Associated Brokers / Dealers N/A CIK Number 0001848749 Filed Document 0001848749-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-03-12 12:13:45 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity